نتایج جستجو برای: ژن pten

تعداد نتایج: 25032  

2013
Xin He Nicholas Arrotta Deepa Radhakrishnan Yu Wang Todd Romigh Charis Eng

Germline mutations in PTEN have been described in a spectrum of syndromes that are collectively known as PTEN hamartoma tumor syndrome (PHTS). In addition to being mutated in the germline in PHTS, somatic lossof-function PTEN mutations are seen in a wide range of sporadic human tumors. Here, we show evidence of upregulated proteasome activity in PHTS-derived lymphoblasts, Pten knock-in mice and...

2017
Milan S. Geybels Min Fang Jonathan L. Wright Xiaoyu Qu Marina Bibikova Brandy Klotzle Jian-Bing Fan Ziding Feng Elaine A. Ostrander Peter S. Nelson Janet L. Stanford

Background Prostate cancer (PCa) with loss of the tumor suppressor gene PTEN has an unfavorable prognosis. DNA methylation profiles associated with PTEN loss may provide further insights into the mechanisms underlying these more aggressive, clinically relevant tumors. Methods The cohort included patients with clinically localized PCa. Samples taken from the primary tumor were used to determin...

Journal: :Cancer research 2002
Myung-Jin Park Mi-Suk Kim In-Chul Park Hee-Seok Kang Heon Yoo Seok Hee Park Chang Hun Rhee Seok-Il Hong Seung-Hoon Lee

Glioblastoma is a severe type of primary brain tumor and its invasion is strongly correlated with the secretion of matrix metalloproteinases (MMPs). To investigate a role of PTEN, a tumor suppressor gene, in the regulation of hyaluronic acid (HA)-induced invasion of glioma cells, we examined the secretion of MMP-9 in various glioma cells with or without a functional PTEN gene. The secretion of ...

2015
Xiaoxiao Wang Huiqiang Huang Ken H. Young

The phosphatase and tensin homolog gene PTEN is one of the most frequently mutated tumor suppressor genes in human cancer. Loss of PTEN function occurs in a variety of human cancers via its mutation, deletion, transcriptional silencing, or protein instability. PTEN deficiency in cancer has been associated with advanced disease, chemotherapy resistance, and poor survival. Impaired PTEN function,...

Journal: :Genes & development 2000
W Zundel C Schindler D Haas-Kogan A Koong F Kaper E Chen A R Gottschalk H E Ryan R S Johnson A B Jefferson D Stokoe A J Giaccia

In glioblastoma-derived cell lines, PTEN does not significantly alter apoptotic sensitivity or cause complete inhibition of DNA synthesis. However, in these cell lines PTEN regulates hypoxia- and IGF-1-induced angiogenic gene expression by regulating Akt activation of HIF-1 activity. Restoration of wild-type PTEN to glioblastoma cell lines lacking functional PTEN ablates hypoxia and IGF-1 induc...

Journal: :Stroke 2009
Yuan Zhu Andreas Wloch Qun Wu Christian Peters Axel Pagenstecher Helmut Bertalanffy Ulrich Sure

BACKGROUND AND PURPOSE Cerebral cavernous malformations (CCMs) are prevalent cerebral vascular lesions involving aberrant angiogenesis. However, the underlying mechanism is poorly understood. Phosphatase and tension homolog deleted on chromosome 10 (PTEN), a tumor suppressor, is frequently deficient in various pathologies due to mutation or epigenetic alterations. PTEN promoter hypermethylation...

Journal: :Cancer 2011
Sherry C Huang Jeffrey K Lee E Julieta Smith Ryan T Doctolero Akihiro Tajima Stayce E Beck Noel Weidner John M Carethers

BACKGROUND Patients with hamartomatous polyposis syndromes have increased risk for colorectal cancer (CRC). Although progression of polyps to carcinoma is observed, pathogenic mechanisms remain unknown. The authors examined whether familial hamartomatous polyps harbor defects in DNA mismatch repair (MMR), and assayed for somatic mutation of PTEN, a gene inactivated in the germline of some hamar...

Journal: :Blood 2010
Cong Peng Yaoyu Chen Zhongfa Yang Haojian Zhang Lori Osterby Alan G Rosmarin Shaoguang Li

The tumor suppressor gene phosphatase and tensin homolog (PTEN) is inactivated in many human cancers. However, it is unknown whether PTEN functions as a tumor suppressor in human Philadelphia chromosome-positive leukemia that includes chronic myeloid leukemia (CML) and B-cell acute lymphoblastic leukemia (B-ALL) and is induced by the BCR-ABL oncogene. By using our mouse model of BCR-ABL-induced...

2017
Michele Milella Italia Falcone Fabiana Conciatori Silvia Matteoni Andrea Sacconi Teresa De Luca Chiara Bazzichetto Vincenzo Corbo Michele Simbolo Isabella Sperduti Antonina Benfante Anais Del Curatolo Ursula Cesta Incani Federico Malusa Adriana Eramo Giovanni Sette Aldo Scarpa Marina Konopleva Michael Andreeff James Andrew McCubrey Giovanni Blandino Matilde Todaro Giorgio Stassi Ruggero De Maria Francesco Cognetti Donatella Del Bufalo Ludovica Ciuffreda

Combined MAPK/PI3K pathway inhibition represents an attractive, albeit toxic, therapeutic strategy in oncology. Since PTEN lies at the intersection of these two pathways, we investigated whether PTEN status determines the functional response to combined pathway inhibition. PTEN (gene, mRNA, and protein) status was extensively characterized in a panel of cancer cell lines and combined MEK/mTOR i...

Journal: :Development 1999
H Huang C J Potter W Tao D M Li W Brogiolo E Hafen H Sun T Xu

Mutations in the tumor suppressor gene PTEN (MMAC1/TEP1) are associated with a large number of human cancers and several autosomal-dominant disorders. Mice mutant for PTEN die at early embryonic stages and the mutant embryonic fibroblasts display decreased sensitivity to cell death. Overexpression of PTEN in different mammalian tissue culture cells affects various processes including cell proli...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید